DSM acquires Brazilian state-of-the-art fermentation facility from Amyris

005ebcff-564e-441c-9869-ed25f6fb9f99articleimage.jpg

20 Nov 2017 --- Royal DSM a global science-based company active in health, nutrition and materials and Amyris, Inc, the industrial bioscience company, have enhanced their strategic alliance through the sale of Amyris Brasil Ltda to DSM and the establishment of a long-term manufacturing partnership for Amyris' high-volume products.  

The consideration for Amyris Brasil Ltda, which owns and operates the Brotas 1 production facility, and intellectual property related to farnesene, a bio-based key intermediate for many applications, is US$58 million. 

On top of this, there is an additional value share arrangement over a three-year period amounting to US$37.5 million. In addition to the consideration upfront, there is potential for a future value share in line with Amyris' business model.

DSM will continue existing supply-agreements to Amyris and other parties and will also supply Amyris with specialty compounds until it realizes its Brotas 2 specialties production facility. 

Speedy construction 
Amyris says it is accelerating the construction of its second facility which will be dedicated to specialty products while maintaining the manufacturing process development and business support capability located in Campinas, Brazil.

The transaction is subject to the usual conditions and is expected to close in the next few months.

With the acquisition of the Brotas 1 facility, DSM adds a state-of-the-art biotechnology-based production site in Brazil to its global network, with abundant availability of sustainable raw materials, namely sugar cane, securing production capacity for its rich pipeline of sustainable and bio-based solutions. 

Having broad experience in operating large-scale fermentation plants, DSM will optimize the operational performance of the site.

The strategic alliance between DSM and Amyris started in May 2017 with an equity investment by DSM in Amyris and has since been expanded with several significant product development collaborations.  

The sale of the Brotas 1 facility, which was designed to produce high volumes of farnesene, together with the creation of a long-term production relationship for high-volume farnesene-based intermediates, will enable Amyris to focus on its core strength of developing breakthrough bioscience technologies, says DSM. 

The company will continue to target key markets and concentrate on the production of specialty products.

“Following our equity investment in Amyris and subsequent product development cooperation, I am pleased that we can add a state-of-the-art fermentation-based production facility to our network,” said Chris Goppelsroeder, President & CEO of DSM Nutritional Products.

“Our know-how in fermentation, downstream process development and large-scale manufacturing will allow us to further improve the operational performance of the facility while further strengthening our strategic alliance with Amyris.”

Amyris President & CEO, John Melo, adds how pleased the company is with the continued strategic alliance with DSM. 

“This manufacturing partnership and the sale of our Brotas 1 factory allows us to accelerate the development and manufacturing of specialty, high-performance ingredients,” he said.

“We are building a specialty plant at Brotas (Brotas 2) and also expect to complete our São Martinho plant to focus on sweeteners. The combination of these actions provides us the manufacturing footprint to meet our current demand through the next three to five years and to manage this within our funding constraints.”

“This transaction completes a planned shift from operating a plant originally designed to produce high volumes of farnesene, to producing an expanding number of high-value, specialty ingredients. This shift will allow Amyris to improve returns and cash flows in order to continue to provide sustainable growth for Amyris and its partners.”

To contact our editorial team please email us at editorial@cnsmedia.com

DSM Food Specialties

Collapse

Our aim is to help customers succeed in their markets through strong innovation, exceptional application expertise and insight into the many, ever-changing needs of consumers worldwide.

For food, beverage and supplement manufacturers we offer the comprehensive resources needed to provide customized solutions. Scientific excellence aside, that means a deep knowledge and understanding of markets, consumers and the defining trends in our industry. Namely:

A sharp focus on health benefits: Consumers across the world want to look and feel better. The empowerment and awareness of consumers from India to Indiana is a defining trend in food and beverage nutrition, which we meet through our family of nutritional ingredients and products.

Taste is a key qualifier: If a product doesn’t taste good it doesn’t stand much chance of success. As the world’s tastes and preferences evolve and expand, we are increasingly helping customers innovate, with exciting, authentic and regional flavors and ingredients provided in a streamlined and efficient way.

The drive for convenience: Despite the trend for health foods, time-pressed consumers are looking to buy more processed and convenience food than ever. DSM is committed to helping customers address the need for fast, high-quality products.

Food safety and quality: Our ingredients are based on solid scientific evidence and application knowledge based on decades of experience in our markets. We’re well aware that food safety and compliance is paramount for growing and ambitious food brands.

Related Articles

Food Ingredients News

Non-EU countries face new antibiotic rules on meat imports

20 Jul 2018 --- Countries wanting to import meat into Europe will now have to abide by EU laws on antibiotics as part of a new regulation on veterinary medicine. European Parliament has decided that products of animal origin imported by third countries will now have to meet the EU’s requirements of antibiotics use.

Food Ingredients News

Sensient execs on Mazza buy: “We want to take everything out of the botanical”

20 Jul 2018 --- Sensient is eyeing the newly acquired botanical extraction company Mazza Innovation as a strategic pillar for all of its business operations, including colors and flavors. Presented under the new name of “Sensient Natural Extraction” and continuing to operate out of Canada, the new business unit provides a clean extraction opportunity for Sensient Technologies Corp. The acquisition will offer opportunities in sustainability, cost reduction and clean label, as the entire botanical being used can be broken down and distributed among the diverse companies that comprise Sensient.

Food Ingredients News

Weekly Digest: Symrise nominated for Sustainability Award, innovation in cricket protein flours

20 Jul 2018 --- Symrise has been nominated for the German Sustainability Award. Cricket protein brand Seek, has launched a new line of high protein and sustainable baking flours. Michel Burla, Managing Director of the Cereals and Ingredients Division of the Hochdorf Group, is to step down at the end of this year and GEA has been working with Almarai Company in Saudi Arabia to build the nation’s largest and most modern dairy processing facility.

Food Ingredients News

Unilever: Brazil truckers’ strike “a significant headwind”

20 Jul 2018 --- Unilever’s half-year results have been impacted by an extended truckers strike in Brazil while overall “challenging market conditions” have also affected the British-Dutch transnational consumer goods company. Net profit dropped from €3.3bn (US$3.8bn) to €3.2bn (US$3.7bn) in the first half of the year. Turnover also fell five percent to €26.4bn (US$30.6bn).

Food Ingredients News

Cambridge Commodities acquires ingredient business of US wholesaler Earth Circle Organics

19 Jul 2018 --- UK-based ingredient supplier Cambridge Commodities has acquired the ingredient business of US wholesaler Earth Circle Organics LLC, for an undisclosed sum. Following the acquisition, Earth Circle Organics’ raw and organic superfood ingredient business will merge with the US arm of Cambridge Commodities to create a new division, operating as Earth Circle Ingredients.

More Articles